AstraZeneca said losses on Vaxzevria were the main factor that shaved seven percentage points off its Reported Gross Profit Margin, which fell to 73.5 percent in the first half of the year.
Grow Your Business, Not Your Inbox
Stay informed and join our daily newsletter now!
July 30, 2021 3 min read
This story originally appeared on The Epoch Times
AstraZeneca, which pledged to provide its COVID-19 vaccine at no profit for the duration of the pandemic, said Thursday that losses in the first half of the year on its vaccine shaved 4 cents off the pharmaceutical giant’s
→ Continue reading at Entrepreneur